REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Common Stock, Value, Issued in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly Common Stock, Value, Issued history and growth rate from Q3 2018 to Q3 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Common Stock, Value, Issued for the quarter ending September 30, 2024 was $3.34K, a 47.6% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.34K +$1.08K +47.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.98K +$717 +31.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.79K +$747 +36.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.79K +$747 +36.5% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $2.27K +$221 +10.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.27K +$752 +49.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.05K +$532 +35.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.05K +$602 +41.7% Dec 31, 2022 10-K 2024-04-15
Q3 2022 $2.04K +$706 +52.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.51K +$175 +13.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.51K +$590 +63.9% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.44K +$520 +56.3% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.34K -$4.48M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.34K -$3.96M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $923 -$3.81M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $923 +$305 +49.4% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $4.48M* +$667K Aug 31, 2020 10-Q 2020-10-14
Q2 2020 $3.96M* -$124K May 31, 2020 10-Q 2020-07-07
Q1 2020 $3.81M* -$618K Feb 29, 2020 10-Q 2021-01-14
Q4 2019 $618 -$4.73M Dec 31, 2019 10-K/A 2021-05-07
Q3 2019 $3.81M* -$1.18M Aug 31, 2019 10-Q 2019-10-08
Q2 2019 $4.09M* May 31, 2019 10-Q 2019-07-03
Q1 2019 $4.43M* Feb 28, 2019 10-K 2020-05-04
Q4 2018 $4.73M* Nov 30, 2018 10-Q 2019-01-09
Q3 2018 $5M* Aug 31, 2018 10-Q 2018-10-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.